Logo of envhperEnvironmental Health PerspectivesBrowse ArticlesAbout EHPGeneral InformationAuthorsMediaProgramsPartnerships
Environ Health Perspect. Dec 2001; 109(12): 1215–1226.
PMCID: PMC1240503
Research Article

Assessing the public health benefits of reduced ozone concentrations.

Abstract

In this paper we examine scientific evidence and related uncertainties in two steps of benefit-cost analyses of ozone reduction: estimating the health improvements attributable to reductions in ozone and determining the appropriate monetary values of these improvements. Although substantial evidence exists on molecular and physiologic impacts, the evidence needed to establish concentration-response functions is somewhat limited. Furthermore, because exposure to ozone depends on factors such as air conditioning use, past epidemiologic studies may not be directly applicable in unstudied settings. To evaluate the evidence likely to contribute significantly to benefits, we focus on four health outcomes: premature mortality, chronic asthma, respiratory hospital admissions, and minor restricted activity days. We determine concentration-response functions for these health outcomes for a hypothetical case study in Houston, Texas, using probabilistic weighting reflecting our judgment of the strength of the evidence and the possibility of confounding. We make a similar presentation for valuation, where uncertainty is due primarily to the lack of willingness-to-pay data for the population affected by ozone. We estimate that the annual monetary value of health benefits from reducing ozone concentrations in Houston is approximately $10 per person per microgram per cubic meter (24-hr average) reduced (95% confidence interval, $0.70-$40). The central estimate exceeds past estimates by approximately a factor of five, driven by the inclusion of mortality. We discuss the implications of our findings for future analyses and determine areas of research that might help reduce the uncertainties in benefit estimation.

Full Text

The Full Text of this article is available as a PDF (570K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Dockery DW, Pope CA., 3rd Acute respiratory effects of particulate air pollution. Annu Rev Public Health. 1994;15:107–132. [PubMed]
  • Moolgavkar SH, Luebeck EG. A critical review of the evidence on particulate air pollution and mortality. Epidemiology. 1996 Jul;7(4):420–428. [PubMed]
  • Pope CA, 3rd, Bates DV, Raizenne ME. Health effects of particulate air pollution: time for reassessment? Environ Health Perspect. 1995 May;103(5):472–480. [PMC free article] [PubMed]
  • Schwartz J. Air pollution and daily mortality: a review and meta analysis. Environ Res. 1994 Jan;64(1):36–52. [PubMed]
  • Thurston GD. A critical review of PM10-mortality time-series studies. J Expo Anal Environ Epidemiol. 1996 Jan-Mar;6(1):3–21. [PubMed]
  • Levy JI, Hammitt JK, Spengler JD. Estimating the mortality impacts of particulate matter: what can be learned from between-study variability? Environ Health Perspect. 2000 Feb;108(2):109–117. [PMC free article] [PubMed]
  • Thurston GD, Ito K. Epidemiological studies of acute ozone exposures and mortality. J Expo Anal Environ Epidemiol. 2001 Jul-Aug;11(4):286–294. [PubMed]
  • HILL AB. THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med. 1965 May;58:295–300. [PMC free article] [PubMed]
  • Mudway IS, Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med. 2000 Feb-Apr;21(1-2):1–48. [PubMed]
  • Powell CV, Nash AA, Powers HJ, Primhak RA. Antioxidant status in asthma. Pediatr Pulmonol. 1994 Jul;18(1):34–38. [PubMed]
  • Kinney PL, Thurston GD, Raizenne M. The effects of ambient ozone on lung function in children: a reanalysis of six summer camp studies. Environ Health Perspect. 1996 Feb;104(2):170–174. [PMC free article] [PubMed]
  • Korrick SA, Neas LM, Dockery DW, Gold DR, Allen GA, Hill LB, Kimball KD, Rosner BA, Speizer FE. Effects of ozone and other pollutants on the pulmonary function of adult hikers. Environ Health Perspect. 1998 Feb;106(2):93–99. [PMC free article] [PubMed]
  • Spektor DM, Lippmann M, Thurston GD, Lioy PJ, Stecko J, O'Connor G, Garshick E, Speizer FE, Hayes C. Effects of ambient ozone on respiratory function in healthy adults exercising outdoors. Am Rev Respir Dis. 1988 Oct;138(4):821–828. [PubMed]
  • Hazucha MJ, Bates DV, Bromberg PA. Mechanism of action of ozone on the human lung. J Appl Physiol (1985) 1989 Oct;67(4):1535–1541. [PubMed]
  • Passannante AN, Hazucha MJ, Bromberg PA, Seal E, Folinsbee L, Koch G. Nociceptive mechanisms modulate ozone-induced human lung function decrements. J Appl Physiol (1985) 1998 Nov;85(5):1863–1870. [PubMed]
  • Schelegle ES, Adams WC, Siefkin AD. Indomethacin pretreatment reduces ozone-induced pulmonary function decrements in human subjects. Am Rev Respir Dis. 1987 Dec;136(6):1350–1354. [PubMed]
  • Ying RL, Gross KB, Terzo TS, Eschenbacher WL. Indomethacin does not inhibit the ozone-induced increase in bronchial responsiveness in human subjects. Am Rev Respir Dis. 1990 Oct;142(4):817–821. [PubMed]
  • Folinsbee LJ, McDonnell WF, Horstman DH. Pulmonary function and symptom responses after 6.6-hour exposure to 0.12 ppm ozone with moderate exercise. JAPCA. 1988 Jan;38(1):28–35. [PubMed]
  • Horstman DH, Folinsbee LJ, Ives PJ, Abdul-Salaam S, McDonnell WF. Ozone concentration and pulmonary response relationships for 6.6-hour exposures with five hours of moderate exercise to 0.08, 0.10, and 0.12 ppm. Am Rev Respir Dis. 1990 Nov;142(5):1158–1163. [PubMed]
  • Harkema JR, Plopper CG, Hyde DM, St George JA, Wilson DW, Dungworth DL. Response of macaque bronchiolar epithelium to ambient concentrations of ozone. Am J Pathol. 1993 Sep;143(3):857–866. [PMC free article] [PubMed]
  • Pinkerton KE, Dodge DE, Cederdahl-Demmler J, Wong VJ, Peake J, Haselton CJ, Mellick PW, Singh G, Plopper CG. Differentiated bronchiolar epithelium in alveolar ducts of rats exposed to ozone for 20 months. Am J Pathol. 1993 Mar;142(3):947–956. [PMC free article] [PubMed]
  • Chang LY, Huang Y, Stockstill BL, Graham JA, Grose EC, Menache MG, Miller FJ, Costa DL, Crapo JD. Epithelial injury and interstitial fibrosis in the proximal alveolar regions of rats chronically exposed to a simulated pattern of urban ambient ozone. Toxicol Appl Pharmacol. 1992 Aug;115(2):241–252. [PubMed]
  • Last JA, Gelzleichter T, Harkema J, Parks WC, Mellick P. Effects of 20 months of ozone exposure on lung collagen in Fischer 344 rats. Toxicology. 1993 Nov 12;84(1-3):83–102. [PubMed]
  • Mariassy AT, Abraham WM, Phipps RJ, Sielczak MW, Wanner A. Effect of ozone on the postnatal development of lamb mucociliary apparatus. J Appl Physiol (1985) 1990 Jun;68(6):2504–2510. [PubMed]
  • Tyler WS, Tyler NK, Last JA, Gillespie MJ, Barstow TJ. Comparison of daily and seasonal exposures of young monkeys to ozone. Toxicology. 1988 Jul;50(2):131–144. [PubMed]
  • Liu LJ, Delfino R, Koutrakis P. Ozone exposure assessment in a southern California community. Environ Health Perspect. 1997 Jan;105(1):58–65. [PMC free article] [PubMed]
  • Dockery DW, Pope CA, 3rd, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Jr, Speizer FE. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993 Dec 9;329(24):1753–1759. [PubMed]
  • Pope CA, 3rd, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, Heath CW., Jr Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):669–674. [PubMed]
  • Abbey DE, Nishino N, McDonnell WF, Burchette RJ, Knutsen SF, Lawrence Beeson W, Yang JX. Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med. 1999 Feb;159(2):373–382. [PubMed]
  • Schünemann HJ, Dorn J, Grant BJ, Winkelstein W, Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest. 2000 Sep;118(3):656–664. [PubMed]
  • Beaty TH, Newill CA, Cohen BH, Tockman MS, Bryant SH, Spurgeon HA. Effects of pulmonary function on mortality. J Chronic Dis. 1985;38(8):703–710. [PubMed]
  • Lange P, Nyboe J, Appleyard M, Jensen G, Schnohr P. Spirometric findings and mortality in never-smokers. J Clin Epidemiol. 1990;43(9):867–873. [PubMed]
  • Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996 Sep 21;313(7059):711–716. [PMC free article] [PubMed]
  • Ryan G, Knuiman MW, Divitini ML, James A, Musk AW, Bartholomew HC. Decline in lung function and mortality: the Busselton Health Study. J Epidemiol Community Health. 1999 Apr;53(4):230–234. [PMC free article] [PubMed]
  • McDonnell WF, Abbey DE, Nishino N, Lebowitz MD. Long-term ambient ozone concentration and the incidence of asthma in nonsmoking adults: the AHSMOG Study. Environ Res. 1999 Feb;80(2 Pt 1):110–121. [PubMed]
  • Peters JM, Avol E, Navidi W, London SJ, Gauderman WJ, Lurmann F, Linn WS, Margolis H, Rappaport E, Gong H, et al. A study of twelve Southern California communities with differing levels and types of air pollution. I. Prevalence of respiratory morbidity. Am J Respir Crit Care Med. 1999 Mar;159(3):760–767. [PubMed]
  • Zemp E, Elsasser S, Schindler C, Künzli N, Perruchoud AP, Domenighetti G, Medici T, Ackermann-Liebrich U, Leuenberger P, Monn C, et al. Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA Team. Am J Respir Crit Care Med. 1999 Apr;159(4 Pt 1):1257–1266. [PubMed]
  • Larsen U. The effects of monthly temperature fluctuations on mortality in the United States from 1921 to 1985. Int J Biometeorol. 1990 Dec;34(3):136–145. [PubMed]
  • Jamason PF, Kalkstein LS, Gergen PJ. A synoptic evaluation of asthma hospital admissions in New York City. Am J Respir Crit Care Med. 1997 Dec;156(6):1781–1788. [PubMed]
  • Kalkstein LS, Greene JS. An evaluation of climate/mortality relationships in large U.S. cities and the possible impacts of a climate change. Environ Health Perspect. 1997 Jan;105(1):84–93. [PMC free article] [PubMed]
  • Kelsall JE, Samet JM, Zeger SL, Xu J. Air pollution and mortality in Philadelphia, 1974-1988. Am J Epidemiol. 1997 Nov 1;146(9):750–762. [PubMed]
  • Pope CA, 3rd, Kalkstein LS. Synoptic weather modeling and estimates of the exposure-response relationship between daily mortality and particulate air pollution. Environ Health Perspect. 1996 Apr;104(4):414–420. [PMC free article] [PubMed]
  • Moolgavkar SH, Luebeck EG, Hall TA, Anderson EL. Air pollution and daily mortality in Philadelphia. Epidemiology. 1995 Sep;6(5):476–484. [PubMed]
  • Ito K, Thurston GD. Daily PM10/mortality associations: an investigations of at-risk subpopulations. J Expo Anal Environ Epidemiol. 1996 Jan-Mar;6(1):79–95. [PubMed]
  • Moolgavkar SH. Air pollution and daily mortality in three U.S. counties. Environ Health Perspect. 2000 Aug;108(8):777–784. [PMC free article] [PubMed]
  • Hoek G, Schwartz JD, Groot B, Eilers P. Effects of ambient particulate matter and ozone on daily mortality in Rotterdam, The Netherlands. Arch Environ Health. 1997 Nov-Dec;52(6):455–463. [PubMed]
  • Touloumi G, Katsouyanni K, Zmirou D, Schwartz J, Spix C, de Leon AP, Tobias A, Quennel P, Rabczenko D, Bacharova L, et al. Short-term effects of ambient oxidant exposure on mortality: a combined analysis within the APHEA project. Air Pollution and Health: a European Approach. Am J Epidemiol. 1997 Jul 15;146(2):177–185. [PubMed]
  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. [PubMed]
  • Shumway RH, Azari AS, Pawitan Y. Modeling mortality fluctuations in Los Angeles as functions of pollution and weather effects. Environ Res. 1988 Apr;45(2):224–241. [PubMed]
  • Schwartz J. Particulate air pollution and daily mortality in Detroit. Environ Res. 1991 Dec;56(2):204–213. [PubMed]
  • Dockery DW, Schwartz J, Spengler JD. Air pollution and daily mortality: associations with particulates and acid aerosols. Environ Res. 1992 Dec;59(2):362–373. [PubMed]
  • Fairley D. Daily mortality and air pollution in Santa Clara County, California: 1989-1996. Environ Health Perspect. 1999 Aug;107(8):637–641. [PMC free article] [PubMed]
  • Gwynn RC, Burnett RT, Thurston GD. A time-series analysis of acidic particulate matter and daily mortality and morbidity in the Buffalo, New York, region. Environ Health Perspect. 2000 Feb;108(2):125–133. [PMC free article] [PubMed]
  • Mar TF, Norris GA, Koenig JQ, Larson TV. Associations between air pollution and mortality in Phoenix, 1995-1997. Environ Health Perspect. 2000 Apr;108(4):347–353. [PMC free article] [PubMed]
  • Schwartz J, Morris R. Air pollution and hospital admissions for cardiovascular disease in Detroit, Michigan. Am J Epidemiol. 1995 Jul 1;142(1):23–35. [PubMed]
  • Burnett RT, Dales RE, Brook JR, Raizenne ME, Krewski D. Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology. 1997 Mar;8(2):162–167. [PubMed]
  • Schwartz J. Air pollution and hospital admissions for cardiovascular disease in Tucson. Epidemiology. 1997 Jul;8(4):371–377. [PubMed]
  • Schwartz J. Air pollution and hospital admissions for heart disease in eight U.S. counties. Epidemiology. 1999 Jan;10(1):17–22. [PubMed]
  • Burnett RT, Smith-Doiron M, Stieb D, Cakmak S, Brook JR. Effects of particulate and gaseous air pollution on cardiorespiratory hospitalizations. Arch Environ Health. 1999 Mar-Apr;54(2):130–139. [PubMed]
  • Ostro BD, Rothschild S. Air pollution and acute respiratory morbidity: an observational study of multiple pollutants. Environ Res. 1989 Dec;50(2):238–247. [PubMed]
  • Revesz RL. Environmental regulation, cost-benefit analysis, and the discounting of human lives. Columbia Law Rev. 1999 May;99(4):941–1017. [PubMed]
  • Zanobetti A, Schwartz J, Gold D. Are there sensitive subgroups for the effects of airborne particles? Environ Health Perspect. 2000 Sep;108(9):841–845. [PMC free article] [PubMed]
  • Arthur WB. The economics of risks to life. Am Econ Rev. 1981 Mar;71(1):54–64. [PubMed]
  • Schwartz J. Harvesting and long term exposure effects in the relation between air pollution and mortality. Am J Epidemiol. 2000 Mar 1;151(5):440–448. [PubMed]
  • Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA. 1995 Dec 20;274(23):1852–1857. [PubMed]
  • Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol. 1998 Feb;80(2):189–194. [PubMed]
  • O'Conor RM, Blomquist GC. Measurement of consumer-patient preferences using a hybrid contingent valuation method. J Health Econ. 1997 Dec;16(6):667–683. [PubMed]
  • Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of illness for asthma in the United States, 1985-1994. J Allergy Clin Immunol. 2000 Sep;106(3):493–499. [PubMed]
  • Dudley SE, Gramm WL. EPA's ozone standard may harm public health and welfare. Risk Anal. 1997 Aug;17(4):403–405. [PubMed]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Science

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    Compound
    PubChem Compound links
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...